said acquired patent covers procedures for medizone therapy deactivating certain viruses commonly associated with aids hepatitis and herpes company said patent covers procedures for deactivation viruses human and animal blood and treatment stored blood prior transfusion medizone said acquisition seen significant step enhance company proprietory position company said patent was acquired from unnamed company involved medical research and development for million shares its common stock reuter 